T cell and monocyte/macrophage activation markers associate with adverse outcome, but give limited prognostic value in anemic patients with heart failure: results from RED-HF.
Aurelija AbraitytePål AukrustLei KouInder S AnandJames YoungJohn J V McmurrayDirk J van VeldhuisenLars GullestadThor UelandPublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2018)
https://clinicaltrials.gov/ct2/show/NCT00358215 .